The purpose of this study is to investigate the safety and effectiveness of two dose strengths of study drug compared to placebo in pediatric patients with cystic fibrosis (CF).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
13
The Children's Hospital
Denver, Colorado, United States
General Clinic Research Center University of Minnesota
Minneapolis, Minnesota, United States
The Minnesota CF Center
Minneapolis, Minnesota, United States
respiratory function
adverse events
change in standard safety parameters
pulmonary exacerbation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.